article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

“Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.

article thumbnail

mRNA: A New Era in Biopharmaceutical Contract Manufacturing Market

Roots Analysis

Given such technical and operational challenges associated with the production of RNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the contract manufacturing service providers to cater to the urgent global demand.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How API CMOs can improve containment capabilities without facility acquisition

Pharmaceutical Technology

According to GlobalData analysis, specialist small molecule API capabilities such as containment or controlled substances are driving large contract manufacturing organisations (CMOs) to acquire facilities. Flexible containment solutions for potent APIs. Partnering with containment experts.

article thumbnail

Biologics Contract Manufacturing – Current Interest of the Pharmaceutical Industry

Roots Analysis

Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.

article thumbnail

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

On the other hand, the current trend is for fully closed systems that use negative pressure to keep particles contained inside isolators. Many companies are now prioritising investments in containment systems, GlobalData research shows. But containment is not only important at commercial-stage manufacturing.

article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Premium specialized equipment is necessary because high containment facilities call for the separation of the operator from the product.

article thumbnail

Stevanto Group tackling flexible drug containment packages and filling solutions

Outsourcing Pharma

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.